Global Malaria Action Plan

Global Malaria Action Plan (GMAP)[1] is the first single comprehensive blueprint for global malaria control and elimination. It outlines strategies, costs, goals and timelines designed to build on the trajectory of recent successes in malaria control, moving towards full malaria control and beyond in countries across the globe.

The GMAP was developed by the Roll Back Malaria (RBM) Partnership and endorsed at the 2008 MDG Malaria Summit on September 25, 2008, in New York City.[2]:2[3]

The GMAP presents (i) a comprehensive overview of the global malaria landscape, (ii) an evidence-based approach to deliver effective prevention and treatment to all people at risk and (iii) an estimate of the annual funding needs to achieve the goals of the RBM Partnership for 2010, 2015 and beyond.[4]

The targets of the GMAP are to:

To achieve these targets, the GMAP outlines a three-part global strategy:

  1. control malaria to reduce the current burden and sustain control as long as necessary,
  2. eliminate malaria over time country by country and
  3. research new tools and approaches to support global control and elimination efforts.

The current tools to track implementation of GMAP are so called Country roadmaps.[6]

References

  1. Global Malaria Action Plan
  2. "2008 MDG Malaria Summit: World Leaders Unite - Summary Report" (PDF). 2008. Archived from the original (PDF) on July 18, 2011. Dr. Coll-Seck, Executive Director of the Roll Back Malaria Partnership, opened the Summit by formally launching the Global Malaria Action Plan (GMAP)
  3. "2008 Millennium Development Goals Malaria Summit - Kaiser Network webcast of the event". Henry J. Kaiser Family Foundation. September 25, 2008. Archived from the original on April 10, 2009.
  4. Key Facts, Figures and Strategies: Global Malaria Action Plan , p. 4
  5. Secretary-General Ban Ki-moon addresses a high-level interactive panel to launch the Global Malaria Action Plan
  6. RBM Country Roadmaps
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.